Amarox, the U.K.-unit of India’s Hetero Group, issued a voluntary recall of one batch of sertraline tablets in the United Kingdom after a patient found two different antidepressants packaged together.
The recall, covering 100-mg sertraline tablets, stems from a complaint that flagged a blister strip of a separate drug, 40-mg film-coated citalopram tablets, incorrectly included in the same sealed carton. 

Pharmaceutical supply chains are among the most complex networks, encompassing numerous stakeholders such as manufacturers, distributors, pharmacies, regulators, and healthcare providers. Traditional pharmaceutical supply chains rely on manual processes, fragmented data, and limited visibility. This often causes counterfeiting, drug shortages, and misallocation of crucial medications. In recent years, digitization has emerged as a powerful solution to increase security, efficiency, and transparency in pharmaceutical supply chain management. In this blog, we explore digitalization in pharma and its impact on pharmaceutical supply chain management.

Crescent Pharma Limited is recalling one batch of Ramipril 10mg capsules as a precautionary measure. One blister pack of Ramipril 5mg capsules was found in the a sealed carton of Ramipril 10mg capsules. The MHRA has advised pharmacy and healthcare professionals to stop supplying the impacted batch and return all remaining stock to their suppliers.

Contemporary consumers demand more than just passive experiences when shopping for products in competitive markets. Interactive packaging turns plain transactions into memorable interactions that connect with the brand. Technology integration and innovative design allow for two-way communication between brands and consumers. Traditional packaging is overlooked while interactive features draw attention, leading to increased exploration. The degree to which consumers are engaged correlates directly to brand recall, loyalty, and repurchasing over time. Companies that invest in interactive solutions experience quantifiable returns in the form of increased customer lifetime value.Understanding interaction mechanics helps companies design packaging that resonates with target audiences effectively.

Today’s businesses are not just selling products or services. They are building experiences, capturing attention, and competing in an increasingly fast-moving digital environment. Whether you run a retail store, manage events, or operate a growing brand, one tool is quietly transforming how businesses connect with customers: QR code for businesses. You’ve likely seen QR codes in restaurants, packaging, or advertisements. But they are no longer just a convenience feature. When used strategically, they become powerful tools that can significantly improve customer engagement and directly drive sales. Let’s explore how this works and how businesses can use it effectively.

Choosing between a static and a dynamic QR code for business may seem like a small technical decision. In reality, it can directly impact how effectively you engage customers, track performance, and optimize your marketing efforts. As businesses increasingly rely on tools that bridge offline and online interactions, QR codes have become a key part of that ecosystem. But not all QR codes function the same way. Understanding the difference between a static vs. dynamic QR code is essential for making the right choice based on your business goals.

Predictive AI models can forecast what should be on the shelf, but can’t verify what’s actually there. Closing this execution gap requires augmented reality.

In the pharmaceutical industry, regulatory compliance is not optional but it is the foundation of trust, product safety and patient health. Global regulatory standards are strict but still many pharmaceutical companies have faced serious regulatory actions for noncompliance. These issues not only cause financial losses but also damage the reputation of manufacturing company.

Analyzing the real world issues of non-compliances provides valuable information about what went wrong and how to prevent similar issues in future. In this post we will explore major regulatory failures and the lessons learned from these issues to understand how pharmaceutical manufacturers can strengthen their compliance

culture.

The ultimate intent of manufacturing in the pharmaceutical industry is to produce safe and effective medicines that are appropriate for patients, as well as having met all regulatory and legal requirements. While pharmaceutical products are known to fail at times, even though they may have been manufactured according to GMP quality systems, there continues to be an ongoing problem within the industry concerning failure of pharmaceutical

The recall was triggered after a potential packaging error at the manufacturing site, where two different antihypertensive medicines were incorrectly packaged. Crescent Pharma described the action as a “precautionary measure.” The issue came to light after a pharmacy complaint, when a patient reported that a pack labelled ramipril 5 mg capsules contained blister strips of amlodipine 5 mg tablets inside the sealed carton. 

Crescent Pharma is recalling batch GR164099 of Ramipril 5mg Capsules after packs were found to contain Amlodipine tablets instead due to a packaging error

Pharmaceutical Serialization And Aggregation Solution Refers To A System Used In The Pharmaceutical Industry To Uniquely Identify And Track Each Unit Of A Drug Or Pharmaceutical Product Throughout Its Lifecycle, From Manufacturing To Distribution, And Ultimately To The Patient. Serialization Involves Assigning A Unique Identifier (Serial Number) To Each Product Unit, While Aggregation Refers To The Process Of Linking Individual Product Units (E.g., Bottles Or Cartons) To Their Higher-Level Packaging (E.g., Pallets Or Cases).

Discover how artificial intelligence improves visual inspection accuracy, consistency and compliance in pharmaceutical manufacturing.

Agentic artificial intelligence (AI) gains popularity swiftly. This technology refers to AI systems designed to act autonomously towards specific goals. Agentic AI can plan, decide, take actions, and use tools without constant human prompting. Its goal-oriented behavior and decision-making capabilities make it valuable in different industries, involving healthcare. In this blog, we explore agentic AI in healthcare by focusing on real-world use cases. 

RFID ‌for Pharmaceuticals is a term used to describe the application of Radio Frequency Identification technology in monitoring, identifying, and handling pharmaceutical products at any given moment. RFID employs tags that are loaded with electronic data, readers, and software platforms for the automatic capturing and sharing of information without human intervention.
In contrast to conventional barcode systems, RFID eliminates the need for line-of-sight scanning and can identify several items at once. Therefore, it is perfectly suitable for pharmaceutical settings where precision, quickness, and data validity are of prime ​‍​‌‍​‍‌importance.

En pratique, ces QR codes frauduleux se nichent un peu partout : e-mails, documents numériques ou supports imprimés. Ils poussent insidieusement leurs victimes à délaisser les environnements sécurisés de leur entreprise au profit de terminaux personnels, souvent bien moins protégés. Un simple scan conduit vers de fausses pages imitant habilement des plateformes cloud ou des accès VPN. Le but ? Dérober des identifiants, contourner l’authentification multifacteur (MFA), puis ouvrir la porte à d’autres intrusions.

Built on an innovative, patent-pending antenna architecture, LiquidMate O delivers reliable direct-on-vial RFID tagging for liquid-filled injectable medications, an application long considered one of the most technically challenging in RFID deployment. Ineffective tracking of injectable drugs continues to drive substantial losses through expired inventory, misplaced medications, and regulatory exposure—particularly for high-value or critical products. As enforcement of the U.S. Drug Supply Chain Security Act (DSCSA) accelerates, dependable, high-accuracy RFID-based medication tracking has become essential to both pharmaceutical manufacturing and hospital operations.

Let's be honest—QR codes are underutilized. We've built this remarkable global infrastructure for machine-readable symbols, with error correction baked right into the standard, and we use them almost exclusively as glorified hyperlinks. QPI v1 asked the provocative question: "What if the QR code wasn't a link, but the data itself?" This paper takes that question and runs with it, addressing every practical limitation head-on.

Des équipements de production aux solutions de conditionnement et d’étiquetage, des systèmes d’administration de médicaments aux services CDMO, chaque zone d’excellence proposée par le salon Pharmapack illustre une même réalité : la chaîne de valeur pharmaceutique n’est plus fragmentée, mais interconnectée, collaborative et orientée vers la performance globale. L’innovation ne se limite plus à la molécule. Elle s’exprime désormais à chaque étape du cycle de vie.

Electronic consent systems hold significant promise for improving the informed consent process, particularly in rare disease research. By making the process more accessible, transparent, and user-friendly, eConsent platforms can enhance participant understanding, encourage data sharing, and streamline administrative tasks. The recommendations discussed, i.e. enhancing usability, improving communication, and strengthening data accuracy, are essential steps in ensuring that the consent process is ethical, robust and effective.

RFID in Pharmaceuticals Market is anticipated to expand from $3.2 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of approximately 11.8%. This rapid growth reflects the increasing adoption of Radio Frequency Identification (RFID) technology to enhance tracking, authentication, and management of pharmaceutical products.

From sourcing active pharmaceutical ingredients (APIs) and managing strict cold-chain protocols to navigating evolving regulatory landscapes, the sector faces mounting pressure from internal inefficiencies and external disruptions. Recent years have amplified these challenges, exposing vulnerabilities that threaten both operational continuity and patient outcomes.